The JSE gained for the fourth day on Friday, reaching its best level in four years on Covid-19 vaccine and US stimulus optimism, even as new Covid-19 restrictions threatened sentiment. 

This week, the UK became the first country to authorise emergency use of a vaccine developed by Pfizer and BioNTech, marking another step in the battle against the pandemic...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now